CIC
ORIC icon

Cornercap Investment Counsel’s Oric Pharmaceuticals ORIC Stock Holding History

Cornercap Investment Counsel’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,063
Closed -$103K – 518
2024
Q3 		$103K Sell
10,063
-11,675
-54% -$115K 0.03% 489
2024
Q2 		$154K Buy
+21,738
New +$195K 0.03% 554
2023
Q1 		– Sell
-46,485
Closed -$274K – 630
2022
Q4 		$274K Sell
46,485
-22,606
-33% -$76.3K 0.05% 475
2022
Q3 		$221K Buy
69,091
+38,583
+126% +$154K 0.04% 484
2022
Q2 		$137K Buy
+30,508
New +$122K 0.02% 515

Other funds holding ORIC

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return